Abiopharma

New Form 6-K - Evaxion A/S Filed: 2025-08-11 AccNo: 0001171843-25-005267 Size: 13 KB

New Form 8-K - CervoMed Inc. Filed: 2025-08-11 AccNo: 0001437749-25-025814 Size: 300 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Sonida Senior Living Announces Second Quarter 2025 Results

New Form 10-Q - Aptevo Therapeutics Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106247 Size: 7 MB

New Form 8-K - Aptevo Therapeutics Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106246 Size: 393 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Protara Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001213900-25-073942 Size: 5 MB

New Form 8-K - Theriva Biologics, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-075944 Size: 324 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - 4D Molecular Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106244 Size: 11 MB

New Form 8-K - 4D Molecular Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106243 Size: 324 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Protara Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001213900-25-073937 Size: 275 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Inovio - Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update

New Form 6-K - Cardiol Therapeutics Inc. Filed: 2025-08-11 AccNo: 0001062993-25-014011 Size: 24 KB

New Form SCHEDULE 13G - Protagonist Therapeutics, Inc Filed: 2025-08-11 AccNo: 0000093751-25-000483 Size: 8 KB

New Form SCHEDULE 13G - Premier, Inc. Filed: 2025-08-11 AccNo: 0000093751-25-000482 Size: 8 KB